AI assistant
Sending…
ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2024
May 20, 2024
33148_dirs_2024-05-20_ef91f80f-2912-4f27-86da-8dd92ae15b18.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK: 0001281895
Period of Report: 2024-05-02
Reporting Person: SOUTHWELL DAVID P (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-05-02 | Common Stock | G | 113124 | — | Disposed | 1660 | Direct |
| 2024-05-02 | Common Stock | G | 59716 | — | Disposed | 113124 | Indirect |
Footnotes
F1: The shares of common stock were transferred by the Reporting Person as a gift to The David P. Southwell Irrevocable Trust Dtd 04/14/2024. No funds were exchanged, and no sale of shares occurred in the transfer.
More from ROCKET PHARMACEUTICALS, INC.
Merger & Acquisition
2026
May 28
Regulatory Filings
2026
May 21
Regulatory Filings
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 6
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 27
Regulatory Filings
2026
Mar 2
Regulatory Filings
2026
Feb 26
Annual Report
2026
Feb 26
Director's Dealing
2026
Feb 20